Skip to content
C

Charu Yadav

Publications (4)

Can Turn around Time Compliance in Hospital Laboratories be Set to Auto Pilot Mode? – A 2 Years’ Experience

Charu Yadav, Renu Saxena, V. Kamini & Arun Kumar Harith · Journal of Advances in Medicine and Medical Research · 2022

Background: A short Turn Around Time (TAT) is unanimously desired and equated to efficiency of a hospital laboratory. Despite automation, laboratories often find it difficult to meet the TAT demands. The major lacuna noticed was that our technicians did not know exactly when a sa...

Open access Research Article 10.9734/jammr/2022/v34i2231582

Effect of Time Interval between Collection, Plasma Separation and Analysis and the Effect of Temperature on the Laboratory Results of Plasma Glucose Estimation

Ashish Agarwal, Poornima Ajay Manjrekar, Afzal Ahmad & Charu Yadav · International Journal of Biochemistry Research & Review · 2020

Introduction: In a clinical laboratory, consistency of test results cannot be solely achieved by controlling the accuracy in the analytical phase of glucose estimation alone. Considering the high chances of pre-analytical errors, due consideration has to be given for storage crit...

Open access Research Article 10.9734/ijbcrr/2020/v29i230172

Assessment of Cardiovascular Disease Risk in Prediabetes

Ashish Agarwal, Anupama Hegde, Afzal Ahmad, Charu Yadav, Poornima A. Manjrekar & M. S. Rukmini · International Journal of Biochemistry Research & Review · 2020

Introduction: Prediabetes is associated with dysglycemia, endothelial dysfunction, obesity and inflammation, placing them at an increased risk of cardiovascular events. Aims: The present study aimed to investigate the risk of cardiovascular disease associated with prediabetes by...

Open access Research Article 10.9734/ijbcrr/2020/v29i230166

Evaluation of the Association between Ischemia Modified Albumin (IMA), Glycemic and Lipid Status in Diabetic Nephropathy

Afzal Ahmad, Poornima Manjrekar, Ashish Agarwal, Charu Yadav & Nadia Az Zahra · International Journal of Biochemistry Research & Review · 2019

Introduction: Hyperglycemia induced oxidative stress in Type 2 Diabetes Mellitus modify various biomolecules to cause Diabetic Nephropathy (DN). IMA (Ischemia-Modified Albumin) is one such oxidative stress marker already examined in various clinical events but have not yet been e...

Open access Research Article 10.9734/ijbcrr/2019/v27i230117